Selected research
Market Structure
Global Artemether Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Artemether market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Artemether is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Artemether is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Artemether is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Artemether is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Artemether include Ankang ChiaTai Pharmaceutical, Guangzhou Hanfang Pharmaceutical, Shreeji Pharma International, KPC Pharmaceuticals and HOFON, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Artemether market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Artemether and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Artemether sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Artemether market size, projected growth trends, production technologies, key applications, and end-use industries.
Artemether Segment by Company
Ankang ChiaTai Pharmaceutical
Guangzhou Hanfang Pharmaceutical
Shreeji Pharma International
KPC Pharmaceuticals
HOFON
Artemether Segment by Type
Capsules Artemether
Tablets Artemether
Injectables Artemether
Artemether Segment by Application
Clinic
Hospital
Laboratory
Others
Artemether Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Artemether market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Artemether and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Artemether.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Artemether market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Artemether manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Artemether in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Artemether in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Capsules Artemether
- Tablets Artemether
- Injectables Artemether
Applications
- Clinic
- Hospital
- Laboratory
- Others
Companies covered
- Ankang ChiaTai Pharmaceutical
- Guangzhou Hanfang Pharmaceutical
- Shreeji Pharma International
- KPC Pharmaceuticals
- HOFON
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Artemether Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Artemether Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Artemether Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Artemether Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Artemether Market Dynamics
- 2.1 Artemether Industry Trends
- 2.2 Artemether Industry Drivers
- 2.3 Artemether Industry Opportunities and Challenges
- 2.4 Artemether Industry Restraints
3 Artemether Market by Manufacturers
- 3.1 Global Artemether Revenue by Manufacturers (2021-2026)
- 3.2 Global Artemether Sales by Manufacturers (2021-2026)
- 3.3 Global Artemether Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Artemether Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Artemether Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Artemether Manufacturers, Product Type & Application
- 3.7 Global Artemether Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Artemether Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Artemether Players Market Share by Revenue in 2025
- 3.8.3 2025 Artemether Tier 1, Tier 2, and Tier 3
4 Artemether Market by Type
- 4.1 Artemether Type Introduction
- 4.1.1 Capsules Artemether
- 4.1.2 Tablets Artemether
- 4.1.3 Injectables Artemether
- 4.2 Global Artemether Sales by Type
- 4.2.1 Global Artemether Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Artemether Sales by Type (2021-2032)
- 4.2.3 Global Artemether Sales Market Share by Type (2021-2032)
- 4.3 Global Artemether Revenue by Type
- 4.3.1 Global Artemether Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Artemether Revenue by Type (2021-2032)
- 4.3.3 Global Artemether Revenue Market Share by Type (2021-2032)
5 Artemether Market by Application
- 5.1 Artemether Application Introduction
- 5.1.1 Clinic
- 5.1.2 Hospital
- 5.1.3 Laboratory
- 5.1.4 Others
- 5.2 Global Artemether Sales by Application
- 5.2.1 Global Artemether Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Artemether Sales by Application (2021-2032)
- 5.2.3 Global Artemether Sales Market Share by Application (2021-2032)
- 5.3 Global Artemether Revenue by Application
- 5.3.1 Global Artemether Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Artemether Revenue by Application (2021-2032)
- 5.3.3 Global Artemether Revenue Market Share by Application (2021-2032)
6 Global Artemether Sales by Region
- 6.1 Global Artemether Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Artemether Sales by Region (2021-2032)
- 6.2.1 Global Artemether Sales by Region (2021-2026)
- 6.2.2 Global Artemether Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Artemether Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Artemether Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Artemether Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Artemether Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Artemether Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Artemether Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Artemether Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Artemether Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Artemether Revenue by Region
- 7.1 Global Artemether Revenue by Region
- 7.1.1 Global Artemether Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Artemether Revenue by Region (2021-2026)
- 7.1.3 Global Artemether Revenue by Region (2027-2032)
- 7.1.4 Global Artemether Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Artemether Revenue (2021-2032)
- 7.2.2 North America Artemether Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Artemether Revenue (2021-2032)
- 7.3.2 Europe Artemether Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Artemether Revenue (2021-2032)
- 7.4.2 Asia-Pacific Artemether Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Artemether Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Artemether Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Ankang ChiaTai Pharmaceutical
- 8.1.1 Ankang ChiaTai Pharmaceutical Company Information
- 8.1.2 Ankang ChiaTai Pharmaceutical Business Overview
- 8.1.3 Ankang ChiaTai Pharmaceutical Artemether Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Ankang ChiaTai Pharmaceutical Artemether Product Portfolio
- 8.1.5 Ankang ChiaTai Pharmaceutical Recent Developments
- 8.2 Guangzhou Hanfang Pharmaceutical
- 8.2.1 Guangzhou Hanfang Pharmaceutical Company Information
- 8.2.2 Guangzhou Hanfang Pharmaceutical Business Overview
- 8.2.3 Guangzhou Hanfang Pharmaceutical Artemether Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Guangzhou Hanfang Pharmaceutical Artemether Product Portfolio
- 8.2.5 Guangzhou Hanfang Pharmaceutical Recent Developments
- 8.3 Shreeji Pharma International
- 8.3.1 Shreeji Pharma International Company Information
- 8.3.2 Shreeji Pharma International Business Overview
- 8.3.3 Shreeji Pharma International Artemether Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Shreeji Pharma International Artemether Product Portfolio
- 8.3.5 Shreeji Pharma International Recent Developments
- 8.4 KPC Pharmaceuticals
- 8.4.1 KPC Pharmaceuticals Company Information
- 8.4.2 KPC Pharmaceuticals Business Overview
- 8.4.3 KPC Pharmaceuticals Artemether Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 KPC Pharmaceuticals Artemether Product Portfolio
- 8.4.5 KPC Pharmaceuticals Recent Developments
- 8.5 HOFON
- 8.5.1 HOFON Company Information
- 8.5.2 HOFON Business Overview
- 8.5.3 HOFON Artemether Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 HOFON Artemether Product Portfolio
- 8.5.5 HOFON Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Artemether Value Chain Analysis
- 9.1.1 Artemether Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Artemether Production Mode & Process
- 9.2 Artemether Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Artemether Distributors
- 9.2.3 Artemether Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst